Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F 18 T807 Tau PET Imaging in Frontotemporal Dementia
NCT02707978Phase 2Withdrawn
- Start
- Sep 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flortaucipir in frontotemporal dementia (FTD). Planned start Sep 2017; status: withdrawn.
02
Drugs
flortaucipir
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT02707978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707978.